Cormorant Asset Management, LP - RAIN THERAPEUTICS INC ownership

RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 47 filers reported holding RAIN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of RAIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$26,033
+9.2%
2,978,6600.0%1.71%
+7.5%
Q4 2022$23,829
-99.8%
2,978,660
+28.0%
1.60%
+100.9%
Q3 2022$11,354,000
-12.2%
2,326,6600.0%0.79%
-18.8%
Q2 2022$12,936,000
+9.7%
2,326,6600.0%0.98%
+7.9%
Q1 2022$11,796,000
-60.6%
2,326,6600.0%0.91%
-49.2%
Q4 2021$29,967,000
-13.9%
2,326,6600.0%1.78%
+26.0%
Q3 2021$34,807,000
-12.4%
2,326,660
-11.4%
1.41%
+4.7%
Q2 2021$39,734,0002,626,6601.35%
Other shareholders
RAIN THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,571,379$20,239,0003.93%
Cormorant Asset Management, LP 2,326,660$29,967,0001.78%
BVF INC/IL 2,957,807$38,097,0001.38%
Boxer Capital, LLC 1,175,000$15,134,0000.59%
Perceptive Advisors 4,967,238$63,978,0000.49%
LUMINUS MANAGEMENT LLC 137,428$1,770,0000.42%
Logos Global Management LP 245,161$3,158,0000.33%
Old Well Partners, LLC 13,383$172,0000.11%
Lumina Fund Management LLC 6,000$77,0000.02%
Woodline Partners LP 119,700$1,542,0000.02%
View complete list of RAIN THERAPEUTICS INC shareholders